Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.260
-0.170 (-4.96%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Indaptus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-20.85-15.02-15.42-14.32-7.71
Upgrade
Depreciation & Amortization
-0000
Upgrade
Loss (Gain) From Sale of Assets
----0.02-
Upgrade
Stock-Based Compensation
1.362.312.972.961.51
Upgrade
Other Operating Activities
1.15--0.43-0.11-
Upgrade
Change in Accounts Payable
2.850.47-0.68-1.15-4.24
Upgrade
Change in Other Net Operating Assets
0.67-0.080.16-0.43-0.85
Upgrade
Operating Cash Flow
-14.82-12.32-13.41-13.08-11.29
Upgrade
Capital Expenditures
-----0
Upgrade
Sale of Property, Plant & Equipment
---0.170.45
Upgrade
Investment in Securities
--17.14-16.6-
Upgrade
Investing Cash Flow
--17.14-16.430.45
Upgrade
Short-Term Debt Issued
5.71----
Upgrade
Total Debt Issued
5.71----
Upgrade
Net Debt Issued (Repaid)
5.71----
Upgrade
Issuance of Common Stock
6.45.51--0.39
Upgrade
Other Financing Activities
-0.57-0.76--47.95
Upgrade
Financing Cash Flow
17.544.75--48.34
Upgrade
Net Cash Flow
2.72-7.583.74-29.5137.49
Upgrade
Free Cash Flow
-14.82-12.32-13.41-13.08-11.29
Upgrade
Free Cash Flow Per Share
-15.34-36.88-44.68-44.32-77.31
Upgrade
Cash Income Tax Paid
--000
Upgrade
Levered Free Cash Flow
-8.16-6.86-7.77-7.07-1.99
Upgrade
Unlevered Free Cash Flow
-8.16-6.86-7.77-7.07-1.99
Upgrade
Change in Working Capital
3.510.39-0.52-1.58-5.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.